In addition, HDAC also participates in immunomodulatory networks in cancer cells such as STAT and NF-κB, which not only regulate the expression of molecules in the signal pathway but also controls the nucleus translocation and degradation of STAT and NF-κB signal molecules (Villagra et al., 2010). Here, HDAC9 is linked to cancer.